Has Chandanreddy Devireddy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $121,428 in general payments to Chandanreddy Devireddy, MD across 113 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chandanreddy Devireddy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chandanreddy Devireddy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chandanreddy Devireddy, MD

Interventional Cardiology · Atlanta, GANPI 1356378301

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $105,456 of the $121,428 with a category attached, or 86.8%. 9 manufacturers reported payments, led by Medtronic at 49.3% of the total. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$121,428in general payments, 2019–2025

Across 113 payments — averaging $1074.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$60K
Edwards Lifesciences$55K
Shockwave Medical, Inc$5K
Recor Medical Inc$800
Boston Scientific$186
Abbott$174
plus $89 from 3 others

$1,761,370in research payments, 2019–2025

Across 243 payments — averaging $7248.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$1.4M
Abbott$136K
Recor Medical Inc$75K
W. L. Gore & Associates, Inc.$53K
Shockwave Medical, Inc$52K
Procyrion, Inc.$39K
plus $17K from 1 others

What the payments were for

Consulting fees$105,45687%
Speaking & faculty fees$1,1761%
Travel & lodging$11,62210%
Food & beverage$3,1613%
Education$120%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	89	$59,820
Edwards Lifesciences	16	$55,358
Shockwave Medical, Inc	1	$5,000
Recor Medical Inc	1	$800
Boston Scientific	1	$186
Abbott	2	$174
Asahi Intecc USA, Inc.	1	$48
Cathworks, Inc.	1	$29
Regeneron Healthcare Solutions, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$55,200
SYMPLICITY G3$14,407
RESOLUTE ONYX$8,325
Vascular Lithotripsy$5,000
Resolute$1,176
PARADISE RENAL DENERVATION SYSTEM$800
GENERAL - STRUCTURAL HEART$186
COREVALVE EVOLUT R$162
Mitra Clip system$147
CoreValve Evolut$130

How this compares

$121,428 in reported general payments places this provider in the 90th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia →

Medicare billing

Part B allowed, 2024

$156,776

Medicare patients

460

Services billed

1,002

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	77	$81,854
XareltoRivaroxaban	25	$22,022
BrilintaTicagrelor	14	$10,503
Prasugrel Hcl	15	$1,745
Metoprolol Succinate	47	$749
Isosorbide Mononitrate ErIsosorbide Mononitrate	33	$547
ClopidogrelClopidogrel Bisulfate	71	$515
Atorvastatin Calcium	67	$500
Carvedilol	59	$408
Losartan Potassium	38	$311
Nitroglycerin	16	$280
Lisinopril	23	$230
Amlodipine Besylate	42	$213
Pantoprazole Sodium	28	$185
Atenolol	15	$156

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Atlanta

William NicholsonAtlanta$1000K
David KandzariAtlanta$982K
Pradeep YadavAtlanta$656K
Adam GreenbaumAtlanta$238K
Wissam JaberAtlanta$222K
Katherine KunkelAtlanta$189K
James StewartAtlanta$174K
Pratik SandesaraAtlanta$165K
Prashant KaulAtlanta$109K
Nikoloz ShekiladzeAtlanta$108K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →